Abstract
Prostaglandin E2 (PGE2), originally discovered as a pro-inflammatory mediator, also inhibits several chemoattractant-elicited neutrophil functions, including adhesion, secretion of cytotoxic enzymes, production of superoxide anions, and chemotaxis. In this study, we have examined the effects of PGE2 and prostaglandin E (EP) receptor-selective agonists/antagonists on several steps of the formyl-methionyl-leucyl-phenylalanine (fMLP)-induced phospholipase D (PLD) activation pathway in human neutrophils to elucidate the PGE2 inhibitory mechanism. PGE2 and EP2 receptor agonists inhibited the stimulation of the activity of PLD induced by fMLP in a concentration-dependent manner. The fMLP-stimulated translocation to membranes of protein kinase C α, Rho, and Arf GTPases was diminished in the presence of PGE2 or EP2 agonists. Moreover, PGE2 and EP2 agonists decreased the activation of phosphatidylinositol 3-kinase γ (PI3Kγ) and Tec kinases as well as the tyrosine phosphorylation of proteins stimulated by fMLP. These data provide strong evidence that 1) the inhibitory effects of PGE2 on the fMLP-induced PLD activation pathway were mediated via EP2 receptors and that 2) the suppression of PI3Kγ activity was the crucial step in the EP2-mediated inhibition of the fMLP-induced signaling cascade.
- Received November 17, 2003.
- Accepted April 27, 2004.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
In this issue
Prostaglandin E2 Inhibits the Phospholipase D Pathway Stimulated by Formyl-methionyl-leucyl-phenylalanine in Human Neutrophils. Involvement of EP2 Receptors and Phosphatidylinositol 3-kinase γ
